Medical News

RSS

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Kinetic Concepts, announced today an agreement to license Wright Medical Group, GRAFTJACKET brand for use in marketing the LifeCell™ acellular human dermal-based regenerative tissue matrix for wound applications such as diabetic foot ulcers and venous stasis ulcers.

31 Jan 2011

Alexion announces acquisition of Taligen Therapeutics

Alexion Pharmaceuticals, announced that it has acquired Taligen Therapeutics, a privately held development-stage biotechnology company based in Cambridge, Mass.

31 Jan 2011

Scientists to commence new DNA vaccine trial for use in patients with leukemia

A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK. The treatment will use a new DNA vaccine, developed by scientists from the University of Southampton, which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia - two forms of bone marrow and blood cancer.

31 Jan 2011

Jiangsu Aosaikang Pharmaceutical to take 5% equity position in Living Cell Technologies

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), a global company pioneering the development of a cell implant therapy to treat diabetes, today announced that a binding subscription agreement has been executed in relation to share placement with Jiangsu Aosaikang Pharmaceutical Co., Ltd. (“ASK”). The proposed placement is for the issue of 14,334,080 LCT shares at A$0.12 per share, to raise A$1.72m. This represents a 5% equity stake in LCT, the funds to be received by LCT from ASK not later than 4 March 2011.

31 Jan 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

Patients unaware of stroke risk with irregular heart beat conditions

Thousand of people who suffer from irregular heartbeats or conditions termed as arrhythmias are unaware they are at high risk of suffering a stroke. A new survey found that two of three people do not know the warning signs of shortness of breath and palpitations. Experts estimate that more than 4,000 strokes a year could be prevented by better awareness among the general public and doctors of the heart condition atrial fibrillation (AF) this manifests as palpitations and irregular heart beat.

31 Jan 2011

New nicotine addiction mechanism revealed

A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a “sub-unit” of a receptor protein sensitive to nicotine.

31 Jan 2011

Water contamination warnings after floods

The public has been warned to stay out of some southeast Queensland waterways containing high levels of sewage contamination from floodwaters. Moreton Bay itself has avoided major sewage contamination says the Queensland Government.

31 Jan 2011

Extreme morning sickness drug comes at a price

Women, who suffer from an extreme form of morning sickness called hyperemesis gravidarum (HG), are shelling out $7,000 for a drug not yet approved for use by expectant mums because they are desperate to control their illness. HG leads to severe nausea, dehydration and fatigue and may require hospitalization. It affects up to 3 per cent of pregnant women - about 9,000 per year in Australia. It may lead to termination of the pregnancy.

31 Jan 2011

$61 million anti-tobacco campaign launched to prevent lung cancer

The Australian Federal Government is backing a $61 million advertising campaign to stop smoking. This is the nation’s biggest anti-tobacco campaign. The message is graphic and simple: every cigarette brings cancer closer. Health groups have backed the campaign but advertising industry experts say the public has become increasingly immune to scare campaigns.

31 Jan 2011

Computer glitch gives two women all clear from breast cancer wrongly

Two Victorian women were diagnosed with breast cancer 3 months after a computer error wrongly cleared them of the disease. This happened at BreastScreen Victoria. Authorities, after a bungle in images and patient details, had to re-examine about 5,000 mammograms of various women in November. The re-examination started before Christmas found 5,336 women to be all-clear and two were found to have breast cancer. One result will be unknown for six months because of unrelated medical reasons. Of the all-clear group two women with cancer were declared clear wrongly.

31 Jan 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Warwick research opens new strategy in vehicle design for drug release

The ability of some forms of plankton and bacteria to build an extra natural layer of nanoparticle-like armour has inspired chemists at the University of Warwick to devise a startlingly simple way to give drug bearing polymer vesicles (microscopic polymer based sacs of liquid) their own armoured protection.

31 Jan 2011

Cohort Review Committee evaluates SCIB1 dose escalation, safety in Phase 1 trial

Scancell Holdings Plc, the developer of therapeutic cancer vaccines, is pleased to announce that the first group of patients receiving the lowest dose of SCIB1 in the Phase I clinical trial has been evaluated by the Cohort Review Committee.

31 Jan 2011

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, have received a Paragraph IV Certification Notice from Mylan Technologies advising of the filing of an Abbreviated New Drug Application for a generic version of LIDODERM.

31 Jan 2011

EU grants 3.3 million to AMP for gene therapy development against AIP

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Union has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT is a member, for the development of a gene therapy product for Acute Intermittent Porphyria.

31 Jan 2011

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

Retired San Francisco real estate developer Douglas Rosenberg says he has a new job - helping to find a cure for Alzheimer's disease. Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist is betting at least $3.5 million that Buck faculty Dale Bredesen, MD has the correct take on how to thwart the memory robbing disease that affects over 5 million Americans.

31 Jan 2011

U.S. District Court grants preliminary injunction, clears sale of Dr. Reddy's Allegra D24 tablet

Dr. Reddy's Laboratories announced today that on Friday, 28 January 2011, the U.S. District Court of New Jersey filed a Stipulation and Order lifting an earlier motion for preliminary injunction and clearing the sale of Dr. Reddy's generic product version of Allegra D24, which was approved by the FDA on March 16, 2010.

31 Jan 2011

New study: Super Bowl loss is linked to increased death rates in older individuals

A new study published in the journal Clinical Cardiology reveals that a Super Bowl loss for a home team was associated with increased death rates in both men and women and in older individuals.

31 Jan 2011

Liberty Healthcare: Sex offenders in Indiana less likely to be re-incarcerated

According to state data, sex offenders in Indiana are significantly less likely to be re-incarcerated compared to national figures. Only 17, or 1.7 percent, of 997 sex offenders released from prison in 2006 were convicted for a new sex crime within three years, a state recidivism analysis conducted in 2010 showed.

31 Jan 2011

Medical News

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Alexion announces acquisition of Taligen Therapeutics

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Jiangsu Aosaikang Pharmaceutical to take 5% equity position in Living Cell Technologies

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Patients unaware of stroke risk with irregular heart beat conditions

New nicotine addiction mechanism revealed

Water contamination warnings after floods

Extreme morning sickness drug comes at a price

$61 million anti-tobacco campaign launched to prevent lung cancer

Computer glitch gives two women all clear from breast cancer wrongly

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Warwick research opens new strategy in vehicle design for drug release

Cohort Review Committee evaluates SCIB1 dose escalation, safety in Phase 1 trial

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

EU grants 3.3 million to AMP for gene therapy development against AIP

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

U.S. District Court grants preliminary injunction, clears sale of Dr. Reddy's Allegra D24 tablet

New study: Super Bowl loss is linked to increased death rates in older individuals

Liberty Healthcare: Sex offenders in Indiana less likely to be re-incarcerated

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News